The diagnosis of PML accompanied MRA normally belongs to the field of the nervous system. Disorders in which clinical performance is complex and often involves multi-system congestion. Early identification and standardized clinical care are essential for improving prognosis.
The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation. The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of PML accompanied MRA normally requires individualized development of treatment programs, usually including multidimensional management, including drug therapy, rehabilitation interventions, and regular follow-up visits.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many of the neural system disorders that have been difficult to treat have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adjusted in a timely manner according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the normal integrated management of PML with MRA.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.